Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo) [Phase 3]

View source ↗

Summary

Phase 3 trial update for tirzepatide (LY3298176) in adults with type 2 diabetes on metformin with or without sulfonylurea (SURPASS-AP-Combo) has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2023-01-06